Aim: We performed meta-analysis to determine effect of alcohol relapse after liver transplantation (LT) for alcoholic cirrhosis on graft histology and survival. Methods: Studies were selected using following criteria: (a) LT for alcoholic cirrhosis, (b) reporting data on liver histology and/or patient survival among relapsers and abstainers, (c) minimum follow-up of 3 years. Random effects model was used to pool data to compare relapsers and abstainers on liver histology and patient survival. Results: On analysis of seven studies, pooled prevalence of self-reported alcohol relapse was 26.3% (18.0-36.7%) over median (range) follow-up of 6.0 (3.7-8.3) years, with annual alcohol relapse rate of 4.7% (3.0-6.4%) for any alcohol use and 2.9% (0.5-5.3%) for heavy alcohol use. Relapsers compared to abstainers had higher odds for graft steatosis [4.1 (2.4-6.9)], steatohepatitis [4.5 (1.4-14.2)], alcoholic hepatitis [9.3 (1.01-85)], advanced fibrosis or cirrhosis [8.4 (3.5-20)]. Relapsers were over 3-fold more likely to die at 10 years of follow-up: [3.67 (1.42-9.50)] without differences in overall or 5-year survival. Recurrent alcoholic cirrhosis occurring in 9% of biopsied patients and 2% of all transplants was responsible for about 20% of all deaths on follow-up after LT. Extra-hepatic malignancy, and cardiovascular events were common causes for patient mortality. Conclusion: Alcohol relapse after LT for alcoholic cirrhosis negatively impacts the graft and longterm patient survival. Studies are needed to develop strategies to reduce alcohol relapse after LT for alcoholic cirrhosis. Short Summary: Alcohol relapse in liver transplant recipients can negatively affect graft histology and patient survival. Strategies to reduce alcohol relapse are needed to preserve graft function?
INTRODUCTION
Alcoholic cirrhosis is a common indication for liver transplantation (LT), and accounts for about 15-40% of all the liver transplants from the US and Europe LT registries (Burra et al., 2010; Singal et al., 2013b) . Five-year graft and patient survival after LT for alcoholic cirrhosis are reported to be similar compared to transplantation for other indications, and better compared to patients transplanted for HCV (Lucey et al., 2009; Burra et al., 2010; Singal et al., 2013b) . Prevalence rates on alcohol relapse after LT for alcoholic cirrhosis are reported to vary from 10% to 50% (Cuadrado et al., 2005; Pfitzmann et al., 2007; Dew et al., 2008; DiMartini et al., 2010 DiMartini et al., , 2011 Faure et al., 2012; Berlakovich, 2014) . Among alcohol dependent subjects without liver disease, about 27-90% report relapse to alcohol use over 3-4-year period (1989; Moos and Moos, 2006; Dawson et al., 2007) . Apart from the duration of follow-up after achieving remission on alcohol use and the severity of alcohol relapse (any use or slip vs. heavy alcohol use or alcohol use disorder), other risk factors determine the risk of relapse such as younger age, polysubstance use, lack of employment, low educational status, evidence of life time drinking problem and poor insight with lack of attempt/s on reducing alcohol use.
Among LT recipients for alcoholic cirrhosis, data on the impact of alcohol relapse on liver graft histology remain scanty and conflicting (Pageaux et al., 1999 (Pageaux et al., , 2003 Bjornsson et al., 2005; Cuadrado et al., 2005; Schmeding et al., 2011; Rice et al., 2013; Egawa et al., 2014) . Further, data on the impact of alcohol relapse on patient survival are variable with 10-year survival rates varying from about 22-70% (Pageaux et al., 1999 (Pageaux et al., , 2003 Bjornsson et al., 2005; Pfitzmann et al., 2007; Schmeding et al., 2011; Faure et al., 2012; Rice et al., 2013; Egawa et al., 2014) . Data are also emerging on occurrence of severe relapse to alcohol use after LT for alcoholic cirrhosis, which is responsible for accelerated graft injury (Erard-Poinsot et al., 2016) .
We performed a meta-analysis of studies reporting data on alcohol relapse, liver histology and patient survival among patients transplanted for alcoholic cirrhosis. The specific aims of our study are to examine the impact of alcohol relapse on liver graft and on patient survival among transplant recipients for alcoholic cirrhosis.
MATERIALS AND METHODS

Identification and selection of studies
Literature search was performed (until August 2016) using PubMed, Ovid, and Embase for citations that evaluated outcomes in patients transplanted for alcoholic liver disease. Search terms used were 'alcoholic cirrhosis' and 'liver transplantation'. In addition, a manual search was made for cross-references from reviewed manuscripts. Search and study selection were independently performed by three investigators (SK, MK and RT).
Criteria for study selection
Studies were included for analysis if the following criteria were met: (a) liver transplantation for alcoholic cirrhosis, (b) data provided on alcohol relapse, (c) data provided on liver histology and or patient survival in recidivists and abstainers and (d) minimum follow-up of 3 years. Review articles, non-English citations, non-human studies and studies not meeting inclusion criteria were excluded. Any conflict was resolved with detailed review of the manuscript and discussion among all the authors. There were two studies from the same institution but these two studies were done in two different time periods and data were not duplicated (Pageaux et al., 2003; Faure et al., 2012) . Of the six studies that had information on liver biopsies, five were done for clinical indications and one study had protocol-based biopsies (Cuadrado et al., 2005) . None of the studies included in the final analysis reported on concomitant use of other substances, the role of polysubstance use on the outcomes could not be examined in this study.
Outcome measure
Primary outcome was impact of alcohol relapse on graft histology. Alcohol relapse was defined as alcohol use after LT, which was stratified to any use or heavy use of alcohol. The secondary outcome was impact of alcohol relapse on 5-and 10-year survival.
Assessment of study quality
Each study included in the analysis was assessed for its quality using the following parameters: (a) reported quantification of alcohol use, (b) comparison of baseline characteristics between relapsers and abstainers, (c) stratification of histology to relapsers and abstainers, (d) blinding of biopsies to relapse, (e) median follow-up greater than or equal to 5 years, (f) data provided on patient survival and (g) description of loss to follow-up and deaths. Each parameter was given a numerical score of 0 or 1 with a maximum score of 7. Studies with a score greater than or equal to 4 were considered good quality.
Data collection
Data were collected on sample size, patient demographics and characteristics, follow-up duration, and rate of relapse. Data were collected for both relapsers and abstainers, on liver biopsy findings, overall patient survival, and survival at 5 and 10 years, and causes of patient mortality. On liver biopsy, steatosis was defined as >5% fat, steatohepatitis as findings of fat along with inflammation and hepatocyte injury (ballooning), fibrosis defined as collagen and extracellular matrix and staging was based on standard Metavir scoring system. Data were collected independently by three different investigators (SK, MK and RT). Any conflict was resolved with detailed review of the manuscript and discussion among all the authors.
Data analysis and statistical methods
Data were entered using the comprehensive meta-analysis software (Biostat, Engelwood, NJ, USA). Random effects model was used to pool the data. Data on alcohol relapse was pooled for any and for heavy alcohol use. These were reported as proportion (95% confidence interval (CI)) and also as incidence (95% CI) per hundred person years of post-transplant follow-up. To determine the incidence of alcohol relapse, variable follow-up across studies was weighted for the sample size in each study, using the Poisson distribution. Median follow-up duration in the study was used, with the assumption that each subject was followed for that time period. Pooled data on liver graft histology and on patient survival were compared for relapsers and abstainers, and reported as odds ratio (OR) (95% CI). Heterogeneity across studies was reported using the I 2 statistics.
At least two studies were needed in analysis for determining heterogeneity. For heterogeneous data, sensitivity analyses were performed after excluding poor quality studies or after excluding two studies with the highest and lowest odds ratio from the initial analysis. Publication bias was assessed with visual inspection of funnel plots and by Egger's regression analysis. P-value <0.05 was considered statistically significant. At least three studies were needed in the analysis to determine publication bias. We did not have manuscript available for one study to be able to access complete data.
RESULTS
Selection of studies
Of the 1239 citations retrieved on initial search, seven studies were included in the final analysis ( Fig. 1 ), six full manuscripts and an abstract publication (Bade and Singal, 2014) . One of the studies analyzed outcomes of alcohol relapse among LT recipients for all the indications (Faure et al., 2012; Bade and Singal, 2014) . The data for patients transplanted for alcoholic cirrhosis were extracted from this study and included in the analysis.
Study characteristics
A total of seven studies including 995 transplant recipients for alcoholic cirrhosis were analyzed (Table 1) . Mean age reported in four studies (N = 505) was 51 years. About 77% (63-87%) of patients were males as reported in six studies (N = 789). The median (range) follow-up duration was 6.0 (3.7-8.3) years. Five of the seven studies were of good quality and remaining two were of poor quality (Faure et al., 2012; Bade and Singal, 2014) (Table 2) .
Prevalence of alcohol relapse
Any alcohol use A total of 264 (27%) patients in all the seven studies reported any use of alcohol on follow-up after liver transplantation with pooled prevalence of 26.3% (95% CI: 18.0-36.7%) over a median follow-up period of 6 years, with an annual incidence rate of about 4.7% (95% CI: 3.0-6.4%). Data on both these analyses were heterogeneous (I 2 = 90 and 93, respectively, P < 0.0001), but without any publication bias (Egger's P = 0.78 and 0.4, respectively). Sensitivity analysis performed after excluding two poor quality studies (Faure et al., 2012; Bade and Singal, 2014) showed pooled prevalence of 26.1% (21.3-31.6%) at 6 years and annual incidence of 4.9% (3.1-6.7%), with homogeneous data for both analyses (I 2 = 39, P = 0.16 and 49, P = 0.09).
Heavy alcohol use Alcohol relapse was defined as daily alcohol intake of more than 30 g/ day (Cuadrado et al., 2005) . Heavy drinking was defined as more than 14 units per week and/or periods of time with more than 4 units per day (Pageaux et al., 2003) . In another study, continuous heavy alcohol use was defined as alcohol use that was continuous or nearly continuous after transplantation without clear intervals of sobreity (Rice et al., 2013) . Amount of alcohol use was reported in only three studies. Of these, 178 (26.8%) reported any alcohol use and 94 (14.2%) used alcohol in heavy amount. Pooled prevalence of heavy alcohol use after liver transplantation was 14.5% over a median follow-up period of 6 years (95% CI: 6.1-30.9%), with an annual incidence rate of 2.9% (95% CI: 0.5-5.3%). Data on both these analyses were heterogeneous (I 2 89.7 and 94.3, respectively, P < 0.0001) without any publication bias (Egger's P = 0.06 and 0.17, respectively). Sensitivity analysis from one study after excluding two poor quality studies showed pooled prevalence of 21.1% (14.9-29.0%) and annual incidence of 4.9% (2.9-6.5%), respectively. Heterogeneity could not be assessed with only one study left in the analysis.
Liver histology
A total of 446 liver biopsies from six studies were analyzed to compare relapsers (N = 141) and abstainers (N = 305) on histological findings (Table 3) . In one study, liver biopsies were performed when clinically indicated, however the biopsy results were not reported (Faure et al., 2012) . Of the remaining five studies, biopsies in four were done for clinical indications, one study had protocol-based biopsies (Cuadrado et al., 2005) . As not every study reported on all the histological lesions, the number of biopsies for different histological outcomes is variable.
Steatosis
Of 391 liver biopsies (129 recidivists) from five studies, steatosis was reported on 76 (43 relapsers) biopsies. Relapsers as compared to 262 abstainers, had higher prevalence of steatosis (33% vs. 13%), with over 4-fold risk for presence of steatosis among recidivists [4.08 (2.41-6.91)]. Data were homogeneous (I 2 = 0, P = 0.53) without publication bias (Egger's P = 0.78).
Steatohepatitis
Of 160 biopsies (49 recidivists) from three studies, steatohepatitis was reported on 24 (15 relapsers) biopsies. Relapsers as compared to 111 abstainers had higher prevalence of steatohepatitis (31% vs. 8%) with over 4-fold risk for presence of steatohepatitis among relapsers, [4.5 (1.4-14.
2)], P = 0.01 ( Fig. 2A ). Data were homogeneous (I 2 = 28, P = 0.25) without any publication bias (Egger's P = 0.54). Of 246 biopsies (85 recidivists) analyzing on alcoholic hepatitis in four studies, one study did not report any case of alcoholic hepatitis, leaving three studies for final analysis. Relapsers as compared to 161 abstainers had higher prevalence of alcoholic hepatitis changes on liver biopsy (5% vs. 0%) with over 9-fold risk for alcoholic hepatitis among relapsers, [9.3 (1.01-85)], P = 0.049 (Fig. 2B ). Data were homogeneous (I 2 = 0, P = 0.61). Publication bias could not be assessed with only two studies in the analysis.
Fibrosis
Of 340 biopsies (108 recidivists) from four studies, 37 (19 relapsers) reported presence of advanced fibrosis or cirrhosis. Relapsers as compared to 232 abstainers had higher prevalence of advanced fibrosis or cirrhosis (18% vs. 8%) with over 8-fold risk for advanced fibrosis or cirrhosis, [8.4 (3.5-20)], P < 0.0001 (Fig. 2C ). Data were homogeneous (I 2 = 0, P = 0.87) without any publication bias (Egger's P = 0.76).
Patient survival
A total of 240 patients died on a median follow-up of about 6.0 years after LT. Five-year survival reported on 824 recipients was similar comparing 224 relapsers and 600 abstainers (86% vs. 88%), OR (95% CI) of 1.2 (0.7-2.1), (Fig. 3A) . Data were homogeneous (I 2 = 20, P = 0.29) without any publication bias (Egger's P = 0.89).
Ten-year survival reported on 692 recipients in four studies was worse among relapsers (N = 184) compared to 508 abstainers (45.2% vs. 65.4%), with over 3-fold risk of death among relapsers: 3.67 (1.42-9.50) (Fig. 3B ). Data were heterogeneous (I 2 = 82, P = 0.001) without any publication bias (Egger's P = 0.28). With only one of four studies of poor quality in the initial analysis, sensitivity analysis performed after excluding two studies with highest and lowest OR showed homogeneous data (I 2 = 36, P = 0.21), with similar effect size: 3.8 (1.6-8.9). Publication bias could not be assessed with only two studies left in the analysis.
Causes of patient mortality
Of 240 patients dying on post-transplant follow-up, causes of death were reported in 175 patients (Table 4) . Of these, 19% died from liver failure related to continued alcohol use. More common causes were malignancy in 42% (non-HCC malignancy in 35%), cardiovascular-related mortality in 17%, and infections in 21%. Remaining patients died from liver failure due to graft rejection (Table 4) .
DISCUSSION
Main findings of this meta-analysis are that alcohol relapse after liver transplantation for alcoholic cirrhosis (a) occurs at a rate of about 4.7% per year for any alcohol use and about 2.9% for heavy alcohol use, (b) negatively impacts the liver graft with risk for development of steatohepatitis, alcoholic hepatitis, and advanced fibrosis or cirrhosis; and (c) negatively impacts the long-term survival. Further, malignancy, graft failure and cardiovascular causes are common causes of patient mortality. Self-reported alcohol relapse rates after liver transplantation for alcoholic cirrhosis vary from 10% to 50% (Pageaux et al., 1999; Cuadrado et al., 2005; DiMartini et al., 2010) . Pooled data of about 26% alcohol relapse rate in this meta-analysis is consistent with the published literature. Alcohol relapse commonly occurs at 2 years after transplantation and then increases with follow-up time (DiMartini et al., 2010; Russ et al., 2016) . In a meta-analysis of 50 studies, annual incidence of alcohol relapse was 5.7% for any alcohol use and 2.5% for heavy alcohol use, similar to incidence rates in this meta-analysis (Dew et al., 2008) .
Among patients with alcohol use disorder without liver disease or receiving any solid organ transplantation, about 90% after achieving remission report at least one alcohol relapse over 4-year period, as reported by the National Institute on Alcohol Abuse and Alcoholism (1989) . In one study, alcohol relapse with alcohol use disorder was reported in about 51% among at risk drinkers, 27% among low risk drinkers and about 7% among abstainers (Dawson et al., 2007) . In another study, over a long-term period of 16 years, patients with alcohol use disorder entering into remission with the use of addiction therapy were less likely to report alcohol relapse compared to remitters without obtaining any help for alcohol use disorder (43% vs. 61%, P < 0.01) (Moos and Moos, 2006) . Other variables influencing relapse rates are reported to be age, psychosocial functioning, educational status, employment status and life time drinking problem (Vaillant et al., 1991; McCallum and Masterton, 2006; Moos and Moos, 2006) . Lack of information on these variables in our study limited our assessment of risk factors predictive of relapse to alcohol use among recipients of LT for alcoholic cirrhosis.
Prevalence of steatosis and steatohepatitis was reported in about 33% and 31% of recidivists undergoing liver biopsy evaluation. There is likely selection bias on these findings as these liver biopsies were driven by clinical indication and were not protocol biopsies. Presence of steatosis and steatohepatitis in 13% and 8% of abstainers may likely be due to post-transplant metabolic syndrome or inaccurate self-report on alcohol use (Watt and Charlton, 2010; Singal et al., 2013a) . Advanced fibrosis or cirrhosis was present in 18% of recidivists in this study. In a recent study, about 32% relapsers showed biopsy changes of advanced fibrosis or cirrhosis on liver biopsy. Protocol biopsies performed in this study, relatively longer duration of about 9 years, and examining only patients with heavy alcohol use likely explains difference between the studies. Overall recurrent alcoholic cirrhosis occurs in about 5-8% of the whole cohort of liver transplant recipients for alcoholic cirrhosis (Dumortier et al., 2015; Verbeek et al., 2016) . In our current analysis, recurrent alcoholic cirrhosis occurred in about 2% of all transplant recipients, about 9% of all biopsied patients, and about 20% of relapsers with heavy alcohol use. Compared to abstainers, relapsers had similar (86% vs. 88%) survival rates at 5 years and lower survival (45% vs. 65%) at 10 years after liver transplantation. These results are similar to a recently reported prospective study on 712 (128 relapsers) patients transplanted for alcoholic cirrhosis, with survival rates comparing relapsers and abstainers at 5 and 10 years of follow-up of 88% vs. 89%, P > 0.05 and 49% vs. 70%, P < 0.005, respectively (Dumortier et al., 2015) . Extra-hepatic malignancy and cardiovascular events were common causes of patient mortality, as reported earlier from single center and on analysis of the NIDDK LT database. Development of malignancy among transplanted patients for alcoholic cirrhosis is associated with smoking (Doycheva et al., 2016; Verbeek et al., 2016) . However, this could not be analyzed in this analysis due to lack of information on smoking in most studies. Graft failure accounted for about 20% of all the deaths in this pooled data.
The data pooled from seven studies with large sample size and stringent criteria for study selection with liver histology comparison of relapsers and abstainers are strengths of our analysis. However, our study suffers from some limitations. For example, all the studies included in this analysis were retrospective or observational with variations on follow-up period and definition of relapse. Also, alcohol use, diagnosis and variability of selection between teams is a limitation of our study. Further, alcohol consumption in all these studies was self-reported, which may often be inaccurate underestimating the true prevalence of alcohol use (Bajaj et al., 2008; Carbonneau et al., 2010) . Moreover, biopsies in all studies were performed for clinical indications and were not protocol biopsies, and thus a potential for selection bias. Not all patients studied had biopsies and only 45% (446 out of 995) had liver biopsies.
In summary, post-transplant alcohol relapse negatively impacts the liver graft and long-term patient survival among transplant recipients for alcoholic cirrhosis. Our study findings highlight the need and importance of maintaining alcohol abstinence after LT. Welldesigned prospective studies are needed for developing strategies to maintain abstinence among LT recipients for alcoholic cirrhosis. Table 4 .
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